CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

TREACE MEDICAL CONCEPTS, INC.

TMCI
$299MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for TMCI. That does not mean none is planned.

Get an email about TMCI's next catalysts

Track TREACE MEDICAL CONCEPTS (TMCI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQSurgical & Medical Instruments & ApparatusMedical devicesπŸ‡ΊπŸ‡ΈNorth AmericaPONTE VEDRA133 employees

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.

Website
Drug Pipeline

No drugs found in this phase.

Frequently asked questions

When is TREACE MEDICAL CONCEPTS, INC.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for TREACE MEDICAL CONCEPTS, INC. (TMCI) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track TMCI biotech catalysts?β†’

Add TMCI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow TREACE MEDICAL CONCEPTS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply